The estimated Net Worth of Public Equities, L.P.Invus ... is at least $1.5 Milione dollars as of 7 August 2024. Public Invus owns over 322,361 units of GlycoMimetics Inc stock worth over $1,010,810 and over the last few years Public sold GLYC stock worth over $490,247.
Public has made over 4 trades of the GlycoMimetics Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Public sold 322,361 units of GLYC stock worth $61,249 on 7 August 2024.
The largest trade Public's ever made was selling 1,379,119 units of GlycoMimetics Inc stock on 26 July 2024 worth over $317,197. On average, Public trades about 567,875 units every 3 days since 2024. As of 7 August 2024 Public still owns at least 6,317,565 units of GlycoMimetics Inc stock.
You can see the complete history of Public Invus stock trades at the bottom of the page.
Over the last 11 years, insiders at GlycoMimetics Inc have traded over $15,299,593 worth of GlycoMimetics Inc stock and bought 10,868,557 units worth $48,421,008 . The most active insiders traders include Scott D Sandell, Peter J Barris e M James Barrett. On average, GlycoMimetics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $38,210. The most recent stock trade was executed by Public Equities, L.P.Invus ... on 7 August 2024, trading 322,361 units of GLYC stock currently worth $61,249.
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.
GlycoMimetics Inc executives and other stock owners filed with the SEC include: